SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Consolidation

Increasingly bold outsourcing will help big pharma cut costs

01-Feb-2011 - Big pharma outsourcing will become much bolder in the next 12-18 months as companies attempt to “dramatically attack cost structures”, according to the Covance CEO.

inVentiv to buy i3 & Campbell Alliance

24-Jan-2011 - inVentiv Health is to acquire i3 and Campbell Alliance and realign into three operating units: clinical, consulting and commercial.

CRI acquires Lifetree to expand Phase I capabilities

20-Jan-2011 - CRI Worldwide has acquired Lifetree Clinical Research to double its Phase I capacity and expand therapeutic expertise.

News in brief

Icon buys Oxford Outcomes to boost Ph IV biz

17-Jan-2011 - Dublin, Ireland-based contract research organisation (CRO) Icon has bought Oxford Outcomes, expanding its late Phase research business.

AMRI merges discovery units

10-Jan-2011 - AMRI has combined its discovery R&D and chemistry units into a single unit it claims will benefit customers.

Top 5 consolidation, cutback & closure articles of 2010

22-Dec-2010 - The contract service market failed to recover as hoped in 2010 and consequently many companies made cutbacks. Outsourcing-Pharma rounds up five of the most read of 2010.

Top strategic partnership news on Outsourcing-Pharma

21-Dec-2010 - Outsourcing-Pharma presents a round up five of our top articles on strategic partnering, which continued apace in 2010, including deals by Covance, PPD and Parexel.

PRA consolidates in Poland to support growth, contain costs

13-Dec-2010 - PRA has relocated its Poland-based early development services and product registration teams into a larger shared office after achieving “solid increases in the placement of clinical studies”.

Cardinal Health acquires Chinese distributer as part of new ‘growth platform’

01-Dec-2010 - US based healthcare distributer, Cardinal Health, has announced the $470m acquisition of privately held healthcare distribution business Zuellig Pharma China, known locally as Yong Yu.

Kendle op profit down 64% as early stage review nears end

10-Nov-2010 - Kendle recorded a 64 per cent drop in Q3 operating income and expects its strategic review of early stage, which will establish a fair value and consider all options, to...

Southern Research gains bioanalytical lab assets in BioCryst acquisition

19-Oct-2010 - Southern Research Institute is acquiring BioCryst Pharmaceuticals’ bioanalytical laboratory assets and personnel in a move towards expanding its bioanalytical service offerings.

BioClinica shareholder calls for managment resignations

04-Oct-2010 - BioClinica shareholder Nicusa Capital is calling for the resignation of CEO Mark Weinstein, CFO Ted Kaminer and Chairman David Nowiki, after describing the firm’s corporate strategy as “defective.”

Covance & Sanofi ink 10-year, $2.2bn strategic R&D alliance

30-Sep-2010 - Covance has inked a 10-year strategic alliance, worth up to $2.2bn, with Sanofi-Aventis and acquired two European sites from the big pharma.

DSM seeks Asian partners; welcomes J&J Crucell takeover

23-Sep-2010 - DSM aims to keep pace with the rapid evolution of pharmaceutical sector through increased partnering and a focus on Asia.

ImmunoSolv & GBC merge; plan contract services growth

01-Sep-2010 - ImmunoSolv is merging with Grampian BioConsultants (GBC) and plans to accelerate development of the contract research business.

Encorium cuts Q2 operating loss despite drop in revenue

18-Aug-2010 - Encorium cut its operating loss to $775,000 in the second quarter despite posting a 17 per cent drop in total revenue.

Cyprotex sees profits down in H1, but predicts US growth

16-Aug-2010 - Pre-clinical ADME contractor Cyprotex upbeat about 2010 despite drop in profit, citing new US opportunities post-Apredica acquisition.

India’s Lambda buys Biovail's research division

09-Aug-2010 - Contract research organization (CRO) Lambda Therapeutic Research has acquired Biovail’s contract research division.

AMRI posts $6m operating loss in Q2; plans expansions

05-Aug-2010 - AMRI recorded a $6.0m (€4.6m) operating loss in the second quarter as restructuring charges and the lack of milestone payments offset contract service gains.

Bilcare to boost EU and US access with €100m Ineos Films buy

03-Aug-2010 - Bilcare to buy Ineos’ rigid polymer films business for €100m ($132m) to improve access to pharmaceutical packaging customers worldwide.

CRL & WuXi discuss Q2 results, life after collapse of deal

03-Aug-2010 - CRL and WuXi have both vowed to independently build their capabilities, to become integrated service providers, but reported mixed financial results.

CRL abandons Wuxi takeover after shareholder opposition

30-Jul-2010 - Charles River Laboratories (CRL) has abandoned plans to buy Wuxi Pharmatech after the $1.6bn (€1.2bn) takeover failed to gain sufficient shareholder support.

Guest article

Pharma consolidation and the downstream impact on CROs

29-Jul-2010 - Significant biopharm consolidation has played a key role in reshaping the drug development sector. Viq Pervaaz, senior vice president at Aon Consulting, discusses the changes and how they will impact...

Icon op income down; “pretty active” in pursuit of M&A

28-Jul-2010 - Icon reported a dip in operating income in the second quarter but an upturn in new business, and the cash to pursue M&A, make it reasonably positive about the future....

Encorium buys Progenitor for vacc biz and global reach

20-Jul-2010 - Encorium has bought Progenitor International Research, furthering efforts to fix its financial woes by focusing on vaccines, oncology and growth in emerging markets.

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...